Loading Brussels time… · EU funding clock ASSESSMENTS OPEN EIC · HORIZON EUROPE · EUROSTARS · LIFE · DIGITAL EUROPE
Open EU grant call

European Partnership on Rare Diseases (ERDERA) (Phase 2)

Index snapshot checked 2026-04-18

european partnership on rare diseases (erdera) (phase 2) horizon europe health anticancer therapy biobanks biomarkers cancer and its biological basis cardiac and cardiovascular systems child health chronic diseases clinical data

Programme Horizon Europe
Deadline 15 Sept 2026
Status Forthcoming
Budget EUR 91.3M

Should you review this call?

This page is a source-backed summary from the current fundingme.eu EU funding index. Review it if your company works in themes covered by the call, can meet the deadline, and has enough evidence to pass the programme's eligibility and scoring rules.

The deadline is 15 Sept 2026, which is 109 days from the current index date. Use the assessment before committing proposal time; keyword fit is not the same as eligibility.

Source summary

european partnership on rare diseases (erdera) (phase 2) horizon europe health anticancer therapy biobanks biomarkers cancer and its biological basis cardiac and cardiovascular systems child health chronic diseases clinical data

Call identifier: HORIZON-HLTH-2026-02

Action type: HORIZON Programme Cofund Actions

View the official source on the EU Funding & Tenders Portal ↗

Indexed themes

  • Anticancer therapy
  • Biobanks
  • Biomarkers
  • Cancer and its biological basis
  • Cardiac and Cardiovascular systems
  • Child health
  • Chronic diseases
  • Clinical data

Related open calls

Data source and freshness

This page is generated from the same grant index used by the fundingme.eu matcher. Deadlines and source links come from the indexed EU Funding & Tenders Portal record. Always verify final conditions on the official source before applying.

Read the matching and data methodology.